| Sep'18 | Sep'17 | Sep'16 | ||||
|---|---|---|---|---|---|---|
OPERATING EXPENSES | ||||||
Research and development, net of recoveries (Note 18) | ||||||
4,873 | 5,726 | 13,060 | ||||
Financing costs | ||||||
911 | 784 | 937 | ||||
General and administration, net of recoveries (Note 18) | ||||||
5,928 | 5,140 | 5,644 | ||||
Total operating expenses | ||||||
11,713 | 11,651 | 19,642 | ||||
Foreign exchange | ||||||
1 | -36 | 79 | ||||
Interest income | ||||||
42 | - | - | ||||
Loss of disposal of equipment (Note 5) | ||||||
83 | - | - | ||||
Gain on derivative liability (Note 8) | ||||||
151 | 7,305 | 6,574 | ||||
Net loss for the year before taxes | ||||||
-11,602 | -4,382 | -12,988 | ||||
Income tax expense (Note 13) | ||||||
27 | 116 | 151 | ||||
Net loss for the year | ||||||
-11,629 | -4,499 | -13,139 | ||||
OTHER COMPREHENSIVE LOSS | ||||||
Cumulative translation adjustment | ||||||
- | - | -337 | ||||
Comprehensive loss for the year | ||||||
-11,629 | -4,499 | -13,477 | ||||
Basic and diluted loss per common share (in dollars per share) | ||||||
-2.55 | -3.09 | -9.77 | ||||
Weighted average number of common shares outstanding - basic and diluted (in shares) | ||||||
4,566 | 1,454 | 1,345 | ||||